Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00526318
Recruitment Status : Unknown
Verified July 2015 by National Cancer Institute (NCI).
Recruitment status was:  Recruiting
First Posted : September 10, 2007
Last Update Posted : July 16, 2015
Information provided by:
National Cancer Institute (NCI)

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2016
  Study Completion Date : No date given